患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Recruiting

• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
• Crohn's Disease
• Australia, Austria, Croatia, Germany, Japan, Lithuania, Netherlands, Poland, United States
• 2018-05-09

• Recruiting

• A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients
• Crohn Disease
• Austria, France, Germany, Italy
• 2018-04-11

• Recruiting

• An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
• Crohn Disease
• Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, Finland, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Moldova, Republic of, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
• 2018-03-12

• Recruiting

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
• Crohn's Disease
• Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Canada, Chile, China, Colombia, Croatia, Czechia, France, Georgia, Germany, Greece, Hungary, India, Ireland, Israel, Italy, Japan, Jordan, Korea, Republic of, Latvia, Lebanon, Lithuania, Macedonia, The Former Yugoslav Republic of, Malaysia, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Switzerland, Taiwan, Tunisia, Turkey, Ukraine, United Kingdom, United States
• 2018-03-08

• Recruiting

• A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
• Crohn Disease
• Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, Finland, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Moldova, Republic of, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
• 2018-02-26

• Recruiting

• Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
• Crohn Disease
• Australia, Austria, Brazil, Bulgaria, Canada, China, Finland, Georgia, Germany, Greece, Hungary, Israel, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Taiwan, Turkey, Ukraine, United States
• 2018-02-14

• Recruiting

• An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
• Neoplasms by Site
• Australia, Austria, Canada, Denmark, Finland, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Switzerland, United Kingdom, United States
• 2013-09-25

• Recruiting

• Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder
• Schizophrenia;Schizophreniform Disorders;Bipolar I Disorder
• Austria, Germany, Ireland, Israel, Italy, Poland, Spain, United Kingdom, United States
• 2017-06-08

• Recruiting

• A randomised trial of nonselective versus selective adjuvant therapy in high risk apparent stage 1 endometrial cancer.
• endometrial cancer
• Australia, Netherlands, New Zealand, United Kingdom
• 2017-05-17

• Recruiting

• The immediate effects of the hOrmone Urocortin on the nerve Control of blood pressure and Heart ratE.
• blood pressure and stable heart failure
• ,Outside, New Zealand
• 2010-07-06